Copay and Savings Messaging in DTC Pharma Media
How pharma uses copay and savings messaging in DTC media: eligibility, federal program limits, compliant presentation, channels, and measurement.
The short answer
Copay and savings messaging tells eligible patients how to lower their out-of-pocket cost for a brand. It must state eligibility clearly, including that manufacturer copay programs generally cannot be used by patients with federal health coverage such as Medicare or Medicaid, avoid implying everyone pays the advertised price, and sit within the promotional review process. It often performs well in search, owned channels, and at the point of decision.
Cost stops many patients from starting or staying on a therapy. Savings programs help commercially insured patients, and messaging tells them the help exists. Done badly, it misleads patients who are not eligible or creates legal risk.
Rules to know
- Federal program exclusion. Manufacturer copay assistance generally cannot be used by patients covered by Medicare, Medicaid, or other federal health programs, because of federal anti-kickback rules. Programs exclude these patients, and messaging must state eligibility.
- Accurate cost claims. "Pay as little as $X" must reflect real terms and limits, with caps and conditions disclosed.
- Promotional review. Savings ads are product promotion and follow the same review, including risk information where required.
- State rules. Some states have rules on copay assistance and how it counts toward deductibles. Check with counsel.
Presenting savings clearly
Include:
- Who is eligible and who is not.
- Program limits: annual maximums, expiration.
- How to enroll.
- That terms may change.
Avoid:
- Leading with a price most patients will not pay.
- Small-print eligibility on a large headline price.
- Implying the drug is free.
Channels
| Channel | Role |
|---|---|
| Search | Captures patients already looking for cost help |
| Brand website | Clear eligibility and enrollment |
| Owned email and text | Reminders to enrolled patients about renewals |
| Point of care and pharmacy | Prompts at the moment of prescribing or filling |
| HCP and staff channels | Practice staff help patients enroll |
| Broad DTC | Short mention, with details on the site |
Measuring savings programs
- Enrollments by channel.
- Activation: share of enrollees who use the card.
- Starts and persistence among users compared with similar non-users, using privacy-safe methods.
- Abandoned prescriptions at pharmacy, where data allows.
Be careful when crediting media. Patients who enroll may already be committed to the drug. Compare against appropriate controls.
Connecting to the journey
Savings messages work best at specific moments:
- After diagnosis, before the first fill.
- At refills, when deductibles reset.
- When coverage changes.
Common mistakes
- Headline prices that most patients cannot get.
- Eligibility exclusions hidden.
- Targeting savings messages broadly, including heavily to older audiences more likely to be on Medicare.
- Counting all enrolled starts as caused by savings media.
Practical takeaway
Check your top savings ad and landing page: is eligibility, including the federal program exclusion, as easy to find as the headline price? If not, fix it before any further media spend.
Frequently asked questions
Can Medicare patients use manufacturer copay cards?
Generally no. Federal anti-kickback rules restrict manufacturer copay assistance for patients in federal health care programs. Copay programs exclude them, and messaging must say so.
Is savings messaging promotional?
Yes. Ads and pages about savings programs for a brand are promotional and go through review, including any required risk information.
What is the best channel for savings messaging?
Channels near the decision work well: search, brand websites, email to enrolled patients, pharmacy, and point of care. Broad awareness channels can mention savings but rarely lead with it.
Sources
- OIG, HHS Office of Inspector General Compliance Resources
- FTC, Health Products Compliance Guidance
- FDA, Basics of Drug Ads
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.